AbbVie, Inc. Units Thailand Depositery Receipts Repr 0.01 ShAbbVie, Inc. Units Thailand Depositery Receipts Repr 0.01 ShAbbVie, Inc. Units Thailand Depositery Receipts Repr 0.01 Sh

AbbVie, Inc. Units Thailand Depositery Receipts Repr 0.01 Sh

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪12.56 T‬THB
68.50THB
‪145.74 B‬THB
‪1.94 T‬THB
‪1.76 B‬
Beta (1Y)
0.39

About AbbVie Inc.


CEO
Robert A. Michael
Website
Headquarters
North Chicago
Founded
2011
ISIN
TH8483124005
FIGI
BBG01X7P11G2
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Check out other big names from the same industry as ABBV19.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
A
ACT4218883
Allergan Funding SCS 4.75% 15-MAR-2045
Yield to maturity
7.00%
Maturity date
Mar 15, 2045
A
ACT3910526
Actavis, Inc. 4.625% 01-OCT-2042
Yield to maturity
6.83%
Maturity date
Oct 1, 2042
A
ACT4176286
Allergan Funding SCS 4.85% 15-JUN-2044
Yield to maturity
6.51%
Maturity date
Jun 15, 2044
XS190919331
Allergan Funding SCS 2.625% 15-NOV-2028
Yield to maturity
5.85%
Maturity date
Nov 15, 2028
ABBV5759196
AbbVie Inc. 5.5% 15-MAR-2064
Yield to maturity
5.56%
Maturity date
Mar 15, 2064
ABBV4911706
AbbVie Inc. 3.2% 21-NOV-2029
Yield to maturity
5.49%
Maturity date
Nov 21, 2029
ABBV5068387
AbbVie Inc. 4.25% 21-NOV-2049
Yield to maturity
5.47%
Maturity date
Nov 21, 2049
ABBV4693583
AbbVie Inc. 4.875% 14-NOV-2048
Yield to maturity
5.46%
Maturity date
Nov 14, 2048
ABBV5759195
AbbVie Inc. 5.4% 15-MAR-2054
Yield to maturity
5.46%
Maturity date
Mar 15, 2054
ABBV6009613
AbbVie Inc. 5.6% 15-MAR-2055
Yield to maturity
5.45%
Maturity date
Mar 15, 2055
US287YAW9
AbbVie Inc. 4.45% 14-MAY-2046
Yield to maturity
5.44%
Maturity date
May 14, 2046

See all ABBV19 bonds